Laidlaw Capital Markets is pleased to announce today’s pricing of a $10,000,000 Follow-On Offering for BioSig Technologies (BSGM). Laidlaw proudly served as the Sole Book Runner on the transaction.

 

See full Press Release on BioSig Website